Dian Diagnostics Group Co.,Ltd. Approves Cash Dividend for 2022
May 22, 2023 at 03:34 pm EDT
Share
Dian Diagnostics Group Co.,Ltd. announced that at the Annual General Meeting of 2022 held on 19 May 2023 approved Cash dividend/10 shares (tax included) of CNY 2.00000000 for 2022.
Dean Diagnostic Technology Group Co., Ltd. is a company providing integrated solutions for medical diagnosis. The Company's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The Company's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The Company's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.